|
17 Mar 2007 |
Micromet and TRACON Pharmaceuticals Sign Exclusive Worldwide License Agreement to Develop and Commercialize D93, a Humanized Antibody for Cancer Treatment
|
|
17 Mar 2007 |
Genmab in Research Cooperation with the Dahanca-Group
|
|
17 Mar 2007 |
Nippon Shinyaku and Teva terminate HMN-214 License Agreement
|
|
16 Mar 2007 |
Emergent BioSolutions Gains Rights To VaxImmune(TM) From Coley Pharmaceutical Group to Expand Its Anthrax Franchise
|
|
16 Mar 2007 |
Trimeris and Roche Amend Research Agreement Covering Next-Generation HIV Fusion Inhibitors
|
|
15 Mar 2007 |
La Merie and PharmaPlus team up to provide No-Frills business intelligence solutions
|
|
15 Mar 2007 |
Bristol-Myers Squibb Significantly Expands Research And Development Presence In India Through Collaborations With Biocon And Accenture
|
|
15 Mar 2007 |
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
|
|
15 Mar 2007 |
Biopartners Holdings AG Purchased by Bioton S.A.
|
|
14 Mar 2007 |
Array BioPharma and VentiRx Pharmaceuticals Announce License Agreement
|
|
14 Mar 2007 |
Kedrion and ProMetic Form Strategic Alliance to Develop Orphan Drugs from Plasma
|
|
14 Mar 2007 |
Maxygen Announces End of Co-Development Agreement
|
|
13 Mar 2007 |
Schering-Plough to Acquire Organon BioSciences
|
|
13 Mar 2007 |
Cangene Receives an Approvable Letter From the FDA for Human Growth Hormone
|
|
13 Mar 2007 |
Oxford Biomedica To Acquire Oxxon Therapeutics
|
|
13 Mar 2007 |
Takeda to Acquire Paradigm Therapeutics
|
|
12 Mar 2007 |
Teva Receives First U.S. Approval For Generic UNIRETIC(R) Tablets
|
|
10 Mar 2007 |
SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals
|
|
10 Mar 2007 |
SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals
|
|
09 Mar 2007 |
Depomed Completes Patient Enrollment In Phase 3 Clinical Trial Of Gabapentin Gr In Postherpetic Neuralgia
|
|
09 Mar 2007 |
Teva Receives Approval For Generic Dostinex(R) Tablets
|
|
08 Mar 2007 |
Stemline Expands its Oncology Pipeline with Acquisition of Clinically Active Compound Directed to "Cancer Stem Cell" Target
|
|
08 Mar 2007 |
ZymoGenetics Provides Update on rhThrombin Development Plans
|
|
07 Mar 2007 |
Clinquest Group and TNO sign licensing agreement on protein for inflammatory disorders
|
|
07 Mar 2007 |
ProNAi and Novosom AG Announce Collaboration to Enable Delivery of DNAi-based Cancer Therapeutics
|
